MISTMilestone Pharmaceuticals Inc.

MIST Stock Price, Valuation & Chart | Milestone Pharmaceuticals Inc.

Compare

$1.180+0.04 (+3.51%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology MIST intrinsic value MIST calculated fair value vs price

Overview Financials Dividends Ratios

MIST Historical price chart

MIST Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization146.91M

PE Ratio-1.74

EPS-0.68

Trading Volume761.73K

Today's High/Low1.19/1.14

Dividend Yield0.00

52 Week High/Low3.06/1.0

Shares Outstanding124.50M

MIST Financial Statement

MIST Analyst ratings

MIST Analysis & performance metrics

MIST Company profile

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing…

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial…

MIST Management team

Name

Position

Joseph G. Oliveto M.B.A.CEO

Chief Executive Officer, President & Director

Jeffrey NelsonCOO

Chief Operating Officer

Amit HasijaCFO

Chief Financial Officer & Executive Vice President of Corporate Development

Guy Rousseau

SVice President of Regulatory Affairs and Quality Management

David B. Bharucha FACC, M.D., Ph.D.

Chief Medical Officer

Kim Fox

Vice President of Communications

Roshan Girglani

Vice President of Marketing

Jeff Moore

Vice President of Sales

Name

Position

Joseph G. Oliveto M.B.A.CEO

Chief Executive Officer, President & Director

Jeffrey NelsonCOO

Chief Operating Officer

Amit HasijaCFO

Chief Financial Officer & Executive Vice President of Corporate Development

Guy Rousseau

SVice President of Regulatory Affairs and Quality Management

David B. Bharucha FACC, M.D., Ph.D.

Chief Medical Officer

Kim Fox

Vice President of Communications

Roshan Girglani

Vice President of Marketing

Jeff Moore

Vice President of Sales

Management Team

Joseph G. Oliveto M.B.A.CEO

Chief Executive Officer, President & Director

Jeffrey NelsonCOO

Chief Operating Officer

Amit HasijaCFO

Chief Financial Officer & Executive Vice President of Corporate Development

Guy Rousseau

SVice President of Regulatory Affairs and Quality Management

David B. Bharucha FACC, M.D., Ph.D.

Chief Medical Officer

Kim Fox

Vice President of Communications

Roshan Girglani

Vice President of Marketing

Jeff Moore

Vice President of Sales

Management

Joseph G. Oliveto M.B.A.CEO

Chief Executive Officer, President & Director

Jeffrey NelsonCOO

Chief Operating Officer

Amit HasijaCFO

Chief Financial Officer & Executive Vice President of Corporate Development

Guy Rousseau

SVice President of Regulatory Affairs and Quality Management

David B. Bharucha FACC, M.D., Ph.D.

Chief Medical Officer

Kim Fox

Vice President of Communications

Roshan Girglani

Vice President of Marketing

Jeff Moore

Vice President of Sales

Total 8 executives

MIST Frequently asked questions

What is Milestone Pharmaceuticals Inc. (MIST) Stock Price?

Current stock price of Milestone Pharmaceuticals Inc. (MIST) stock is $1.180. The stock price is +3.51% higher in the session. The intraday range can be seen from this page. Volume of Milestone Pharmaceuticals Inc. (MIST) stock is 761.73K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Milestone Pharmaceuticals Inc. (MIST) stock price going up or down today?

The stock price of Milestone Pharmaceuticals Inc. (MIST) can change with earnings, company news, and overall market sentiment. Milestone Pharmaceuticals Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Milestone Pharmaceuticals Inc. stock expensive at its current price?

Whether Milestone Pharmaceuticals Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for MIST on this page is -1.74. EPS on this page is -0.68. Compare those figures with peers and growth expectations before deciding if the current Milestone Pharmaceuticals Inc. price is justified.

How has the stock price of Milestone Pharmaceuticals Inc. (MIST) performed historically?

Historical performance for Milestone Pharmaceuticals Inc. (MIST) is shown on the price chart on this page. Review multi-period moves alongside volume to see how MIST reacted to past earnings and market events.

Should I buy Milestone Pharmaceuticals Inc. (MIST) stock, at this price?

Buying Milestone Pharmaceuticals Inc. (MIST) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.